Oxidative stress and inflammation in OSA Source: Eur Respir Mon 2010; 50: 360-380 Year: 2010
Metabolic syndrome, systemic inflammation and oxidative stress in patients with severe obstructive sleep apnea: effects of CPAP Source: Annual Congress 2008 - Metabolic syndrome and systemic inflammation in obstructive sleep apnoea Year: 2008
Association between lipid peroxidation and inflammation in obstructive sleep apnoea Source: Eur Respir J 2006; 28: 378-385 Year: 2006
Relationship of oxidative stress and endothelial dysfunction in sleep apnoea Source: Eur Respir J 2011; 37: 873-879 Year: 2011
Oxidative stress in patients with moderate to severe obstructive sleep apnea Source: Annual Congress 2010 - Biomarkers for oxidative stress, inflammation and cardiovascular function in sleep apnoea Year: 2010
Relationship between upper airway inflammation and systemic inflammation in obstructive sleep apnoea Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA I Year: 2012
Impaired restorative sleep, endotoxaemia and oxidative stress in women with obstructive sleep apnoea Source: International Congress 2019 – Pathophysiological aspects of obstructive sleep apnoea from sea level to high altitude Year: 2019
Circulating KL-6, a biomarker of lung injury, in obstructive sleep apnoea Source: Eur Respir J 2009; 33: 793-796 Year: 2009
Evaluation of 8-isoprostane as a biomarker of oxidative stress in children with obstructive sleep apnea syndrome Source: Annual Congress 2012 - Sleep monitoring, lung function and inflammation in childhood Year: 2012
Upper airway and systemic inflammation in obstructive sleep apnoea Source: Eur Respir J 2016; 48: 1108-1117 Year: 2016
Is snoring the cause of oxidative stress in airways in obstructive sleep apnea patients? Source: International Congress 2015 – Inflammation, biomarkers and hypoxia in sleep disordered breathing Year: 2015
Pathogenic role of angiotensin II and oxidised LDL in obstructive sleep apnoea Source: Eur Respir J 2009; 34: 1390-1398 Year: 2009
Oxidative stress and obstructive sleep apnea syndrome Source: Annual Congress 2008 - Metabolic syndrome and systemic inflammation in obstructive sleep apnoea Year: 2008
Local airway inflammation in obstructive sleep apnoea: the role of leptin Source: Eur Respir J 2006; 28: Suppl. 50, 645s Year: 2006
Pathophysiology of OSA Source: Eur Respir Mon 2010; 50: 31-50 Year: 2010
Signalling pathways in intermittent hypoxia and in obstructive sleep apnoea (OSA) Source: Annual Congress 2007 - Cardiovascular and metabolic consequences of obstructive sleep apnoea: early changes, biomarkers and impact of treatment Year: 2007
Cardiovascular disease in obstructive sleep apnoea syndrome: the role of intermittent hypoxia and inflammation Source: Eur Respir J 2009; 33: 1195-1205 Year: 2009
Carotid body inflammation and cardiorespiratory alterations in intermittent hypoxia Source: Eur Respir J 2012; 39: 1492-1500 Year: 2012
Hypoxic stress in obstructive sleep apnea syndrome (OSAS) activates invasive ability of monocytes Source: Eur Respir J 2005; 26: Suppl. 49, 354s Year: 2005
Obstructive sleep apnoea and COPD Source: Eur Respir Mon 2013; 59: 135-143 Year: 2013